Oxandrolone 10mg
10 mg · 100 tablets · Oral research compound — Oxandrolone 10 mg is a DHT-derived anabolic agent ideal for cutting-phase research, burn injury recovery models, and catabolic state studies. Its low androgenicity and excellent oral bioavailability make it a staple for lean-muscle preservation and precision dosing studies.
€ 55.00
Add to wishlist Add to compare
Description
Oxandrolone 10 mg
Brand: Magnus Pharmaceuticals
Content: 100 tablets | 10 mg per tablet
Price: €55
Manufactured in: Europe
🧪 Product Overview
Oxandrolone 10 mg provides a low-dose, 17-α-alkylated DHT-derived anabolic agent originally known as Anavar. In research settings, it demonstrates strong lean-muscle preservation, improved nitrogen balance, and an exceptionally mild androgenic and hepatic profile relative to most oral AAS compounds.
Its near-100% oral bioavailability and ~23-hour half-life support once- or twice-daily micro-dosing protocols. These features make Oxandrolone an ideal compound for cutting-phase models, burn injury recovery studies, and investigations into catabolic states.
✅ Key Research Highlights
Lean-mass & strength gains:
Significant lean body mass and strength increase in burn and trauma trials with resistance training.
Nitrogen retention:
Reduces net nitrogen loss by 50–70% in hyper-catabolic models.
Low hepatotoxic burden:
Minimal liver enzyme elevation at ≤20 mg/day; rare cases of hepatotoxicity in comparison to similar compounds.
Favourable androgenic ratio:
Roughly 1/3 the androgenicity of testosterone with similar anabolic effects — suitable for female and pediatric research.
Metabolic & anti-catabolic effects:
Enhances muscle protein synthesis and blunts catabolic glucocorticoid signaling.
🔬 Suggested Laboratory Applications
-
Lean muscle preservation during caloric restriction
-
Burn-injury recovery models
-
Pediatric growth and hormone studies
-
Protein catabolism and nitrogen retention studies
📊 Technical Specifications
| Field | Data |
|---|---|
| Chemical Name | Oxandrolone (INN) |
| Chemical Formula | C<sub>19</sub>H<sub>30</sub>O<sub>3</sub> |
| Synonyms | Anavar; Oxandrin; 17α-Methyl-2-oxa-DHT; C19-nor-17α-methylandrosta-2-ene-3,17-diol-one |
| Molecular Weight | 306.4 g/mol |
| CAS Number | 53-39-4 |
| Dose & Strength | 10 mg per tablet · 100 tablets per carton (1,000 mg total) |
| Half-life / PK | t<sub>½</sub> ≈ 23 h · C<sub>max</sub> in 1–2 h · Urinary detection ≤ 6 days |
| Principal Benefits | ↑ Lean body mass, ↓ catabolic loss, mild androgenic profile, oral dosing convenience |
| Key Risks | HDL↓ / LDL↑, transient HPG suppression, rare cholestasis |
| Storage | Store ≤ 25 °C; protect from light & moisture |
| Shelf Life | 36 months (manufacturer specification) |
⚙️ PubChem-Supported Research Insights
-
Improves lean muscle mass and recovery in burn and catabolic models
-
Supports nitrogen retention and protein metabolism
-
Low androgenic risk with favorable anabolic effects
-
High oral bioavailability with minimal hepatotoxic stress at recommended doses
⚠️ Documented Research Side Effects
-
Dose-dependent suppression of HDL with LDL elevation
-
Rare hepatocellular injury at high exposure
-
Temporary HPG axis suppression
-
Detectable in urine for up to 6 days post-exposure
🧯 Handling & Compliance
For Research Use Only – Not for human or veterinary administration
-
Store at ≤ 25°C, protected from light and moisture
-
Follow SDS guidelines for safe handling and disposal
-
Purchase confirms qualified researcher status
There are no reviews yet.
